What is she best known for?
The fields of study she is best known for:
Susan M. Kingsman spends much of her time researching Gene expression, Genetics, Gene, Yeast and Virology.
The Gene study combines topics in areas such as Molecular biology and Immune system.
Her research integrates issues of Cytoplasm, Nucleic acid and Transcription in her study of Molecular biology.
The concepts of her Yeast study are interwoven with issues in Virus-like particle and Transposable element.
She studies Virus which is a part of Virology.
Susan M. Kingsman has included themes like Hypoxia and Viral vector in her Genetic enhancement study.
Her most cited work include:
- Conservation of high efficiency promoter sequences in Saccharomyces cerevisiae. (310 citations)
- Efficient synthesis of enzymatically active calf chymosin in Saccharomyces cerevisiae. (292 citations)
- A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1 gag-pol Gene (248 citations)
What are the main themes of her work throughout her whole career to date?
Susan M. Kingsman mainly focuses on Gene, Molecular biology, Genetics, Virology and Yeast.
Her research related to Transcription, Phosphoglycerate kinase, Gene expression, Plasmid and Coding region might be considered part of Gene.
Her research in Molecular biology intersects with topics in RNA, DNA, Activator, Regulation of gene expression and Binding site.
Her biological study spans a wide range of topics, including Equine infectious anaemia virus, Vector and Genetic enhancement.
Susan M. Kingsman works mostly in the field of Genetic enhancement, limiting it down to topics relating to Hypoxia and, in certain cases, Viral vector.
Susan M. Kingsman interconnects Virus-like particle, Heterologous, Fusion protein and Expression vector in the investigation of issues within Yeast.
She most often published in these fields:
- Gene (36.62%)
- Molecular biology (35.21%)
- Genetics (37.32%)
What were the highlights of her more recent work (between 1999-2009)?
- Genetic enhancement (16.90%)
- Virology (26.76%)
- Gene (36.62%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Genetic enhancement, Virology, Gene, Viral vector and Genetics.
Her Genetic enhancement research is multidisciplinary, relying on both Hypoxia, Bioinformatics, Immune system, Molecular biology and Haemophilia A.
Her Virology study incorporates themes from Equine infectious anaemia virus, Vector, Spinal muscular atrophy and Transduction.
Her Gene research focuses on Gene expression and Codon optimized.
Her Viral vector research includes themes of Equine infectious anemia, Cancer research, Motor neuron and Axoplasmic transport.
Her study in Genetics focuses on Expression vector, RNA splicing, Intron, RNA and Saccharomyces cerevisiae.
Between 1999 and 2009, her most popular works were:
- A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1 gag-pol Gene (248 citations)
- A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1 gag-pol Gene (248 citations)
- The macrophage - a novel system to deliver gene therapy to pathological hypoxia. (191 citations)
In her most recent research, the most cited papers focused on:
Gene, Genetic enhancement, Cancer research, Viral vector and Virology are her primary areas of study.
Her research on Gene concerns the broader Genetics.
Her study explores the link between Genetic enhancement and topics such as Neuroscience that cross with problems in Gene delivery and Glial cell line-derived neurotrophic factor.
Her Cancer research research incorporates elements of Molecular biology, Adenoviridae and Hypoxia.
Her work carried out in the field of Viral vector brings together such families of science as Motor neuron, SMN Complex Proteins, Spinal muscular atrophy and Axoplasmic transport.
Her work in Virology tackles topics such as RNA which are related to areas like Genome, Vector, Codon usage bias, Murine leukemia virus and Coding region.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
